Navigation Links
Niche Pharmaceuticals, Inc. Asks "Are You Ready to Get Your Life Back from Chronic Migraines?"
Date:12/9/2015

SOUTHLAKE, Texas, Dec. 9, 2015 /PRNewswire/ -- Niche Pharmaceuticals, Inc. has launched a microsite (www.MagnesiumRoadtoMigrainePrevention.com) which features an overview of the research done on the link between magnesium deficiency and chronic migraine headaches. Niche Pharmaceuticals invites people with chronic migraine headaches to explore the site to better understand findings on the connection between low magnesium and migraine headaches.

Published clinical trials (1) have shown that daily magnesium supplementation taken for a minimum of two to three months can reduce the occurrence of migraine days by at least fifty percent. Results will vary per individual. In fact, the American Headache Society and the American Academy of Neurology now include oral magnesium in their preventive treatment guidelines for migraines (2). There is strong evidence that magnesium deficiency is much more prevalent in those with chronic migraine headaches than in healthy controls. 

Mag-Tab®SR is Niche's magnesium product that has a unique formulation that delivers magnesium L-lactate dihydrate into the body slowly for maximum absorption. Taken daily, Mag-Tab®SR provides twenty-four hours of continuous magnesium supplementation. The slow release component leads to better uptake in the body's cells and relief of many symptoms associated with magnesium deficiency. 

According to the company's founder and CEO, Steve F. Brandon, studies show(3) approximately four out of five people in the United States do not get enough magnesium in their diet and may be magnesium deficient. Up to fifty percent of the thirty-six million American migraine sufferers have low magnesium levels associated with their chronic migraines (4). This is especially true for women (5). Doctors recommend non-prescription Mag-Tab®SR because it is a sustained release magnesium supplement that is highly absorbed and well-tolerated by the gastrointestinal tract(6).

A "Migraine Prevention" pack with two bottles of one hundred caplets and a free sixty count bottle are available as part of the campaign and can be purchased at http://www.magnesiumroadtomigraineprevention.com. The pack contains two months' worth of daily magnesium intake and participants will receive a discount code for their next purchase at magtabsr.com, the company's website. Migraineurs are invited to share their progress and results on Mag-Tab® SR's Facebook page (www.facebook.com/magtabsr), tweet to @magtabsr, and use the mobile migraine tracking app Migraine Buddy where a Mag-Tab®SR group has been created.

About Niche Pharmaceuticals, Inc.
Niche Pharmaceuticals, Inc. was founded in 1991 to develop and market ethical pharmaceutical grade nutraceutical products that fulfill unmet medical needs. Over the years, Niche has a developed a reputable base of U.S. and International doctors who recommend Mag-Tab®SR, a non-prescription magnesium supplement. Niche has also dedicated considerable financial resources towards developing the first Rx oral magnesium product for the prevention of migraine headaches with major clinical trials now underway across the US.

Media Contact:
Steve Brandon 
Niche Pharmaceuticals, Inc. 
580 Commerce St, Ste. 100 
Southlake, Texas 76092 
800-677-0355
817-421-2777
www.magnesiumroadtomigraineprevention.com
www.magtabsr.com 
info@magtabsr.com

Citations

(1) http://www.ncbi.nlm.nih.gov/pubmed/18705538

(2) http://tools.aan.com/professionals/practice/pdfs/gl0090.pdf

(3) http://www.foxnews.com/health/2013/11/23/7-nutrients-lacking-in-your-diet.html

(4) https://migraine.com/pro/migraine-prevalence-and-incidence/

(5) https://migraine.com/pro/migraine-prevalence-and-incidence/

(6) http://www.magtabsr.com/template/pdf/Bioavailability-and-Pharmacokinetics-of-Mg-After-Admin-of-Mg-Salts-in-Humans.pdf

 

Photo - http://photos.prnewswire.com/prnh/20151207/293835
Photo - http://photos.prnewswire.com/prnh/20151207/293836

 


'/>"/>
SOURCE Niche Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets
2. Percutaneous Coronary Intervention Devices: Niche Opportunities Emerge in Western Europe
3. Global Gelatin and Gelatin Derivatives Isinglass and Bone Glues Market in Europe 2014-2018: Key Vendors are AB Vickers, Corngroup, Fritz Hacker GmbH & Co, Gelita, Kerry Ingredients and Flavours and Menichetti
4. Laboratory Glassware And Plasticware - 2012 Global Strategic Business Report Profiles 91 Companies Including Many Key and Niche Players
5. KaloBios Pharmaceuticals, Inc. Raises $8.2 Million in Private Placement
6. KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New Financing
7. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2015
8. Ground Zero Pharmaceuticals, Inc. (GZP) Announces New Additions, Services for its Global Clients
9. Global Hyperphosphatemia Drugs Market 2015-2019 with Fresenius Medical Care, Keryx Biopharmaceuticals, Sanofi, Shire & Vifor Pharma Dominating
10. ContraVir Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock And Warrants
11. Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
Breaking Medicine News(10 mins):